Blog | Gen Re

Our Perspective

Group Term Life Carriers Brace for Change

By Mike Fullerton |July 16, 2020|English

For nearly two decades, Gen Re has been tracking results for the Group Term Life (GTL) industry. We’ve seen various impacts on the marketplace, from mergers, acquisitions and subsequent growth to serious economic downturns. However, these past...
Read More
Health Consequences of E-Cigarettes [Part 2 of series]

By Dr. Thomas Ashley |July 08, 2020|English

In my first blog in my series on vaping, I described the characteristics of the large, global vaping population. Life insurers care most about the health consequences of e-cigarettes. This segment will touch on several aspects of this concern. The...
Read More
The Demographics of E-Cigarette Users

By Dr. Thomas Ashley |July 01, 2020|English

The use of e-cigarettes and vaping continues to be a novel phenomena affecting our business. Vaping is the use of an inhalant apparatus to deliver nicotine without combustion of tobacco products, also known as electronic nicotine delivery systems, or...
Read More
COVID-19 in India - Why Has the Country Fared Comparatively Well So Far?

By Dr. Sara Kannampuzha |June 19, 2020|English

COVID-19 is one of the main issues currently facing the world, and discussion of topics - including finding a possible vaccine, whether the number of daily infections is decreasing or not, effective social distancing measures, and the overall prognosis...
Read More
The Medical Treatment of COVID-19 - Where Do Things Stand Today?

By Dr. Sandra Mitic |April 23, 2020|English | Español | Deutsch

Viruses are tiny organic structures that are able to invade human cells and multiply inside them. The host cells are either destroyed or at least prevented from performing their normal metabolic functions. As the replication mechanism of most viruses...
Read More
CEA Screening - Useful in Life & Health Underwriting?

By Dr. Thomas Ashley |March 26, 2020|English | Français

Some insurers have added the carcinoembryonic antigen (CEA) blood test to the laboratory screening profile for Life and Health insurance applications, and some of our U.S. clients have asked for advice on whether to adopt this test. Every test has repercussions...
Read More